Overview

Lung cancer is the most common cause of cancer death in Australia. It is often diagnosed late because symptoms can be vague or there may be no symptoms experienced in the early stages of the disease.

Fortunately, the landscape for the management of lung cancer is changing rapidly with advances in research and technological developments bringing new hope through novel screening, diagnostic and treatment approaches. However, the experience of patients with lung cancer is one of a forgotten disease characterised by low public awareness and negative stereotypes. This contributes to delays in diagnosis, lack of support systems and inequitable access to best practice and new treatment approaches.

In particular, stigma towards people with lung cancer plays a major role in delays to diagnosis. Health professionals need to be aware of the symptoms of lung disease and the increasing trend of people presenting both with and without smoking as a risk factor. Making assumptions about a diagnosis based only on the presence of risk factors, such as smoking, causes delays in diagnosis and can affect patient health and well-being.

Lung Foundation Australia provides a range of evidence-based resources and initiatives to support early diagnosis and best practice treatment and management of lung cancer.

Australian Lung Cancer Conference

This initiative supports further advancements in lung cancer treatment and care by providing a national platform for clinical education, collaboration, implementation and dissemination of lung cancer research findings. Held biannually since 2006, the conference is attended by over 400 national and international health professionals. The next conference will held in 2020.